The Tech, Tools and Diagnostics Driving Advancements in Precision Medicine
Browse the Marketplace below, or view the digital edition of the comprehensive 2020 Insider’s Guide
Welcome to the Clinical OMICs Marketplace, the industry’s only guide to the technologies and tools advancing precision medicine. Find the solutions to your challenges, drive innovation in your research & development, and close the gap from bench to bedside – get started now.
Marketplace > Oncology > Cancer/Companion Diagnostics > AVENIO ctDNA Surveillance Kits (Roche)

AVENIO ctDNA Surveillance Kits (Roche)

The AVENIO ctDNA Surveillance Kit is an NGS liquid biopsy assay that is specially designed to enable researchers to monitor tumor burden in lung and colorectal cancer over time, as well as to assess for minimal residual disease (MRD). This assay contains 471 frequently mutated regions associated with the presence of disease across 197 genes, including those in the U.S. National Comprehensive Cancer Network (NCCN) Guidelines.


Roche Sequencing and Life Science

9115 Hague Road
Indianapolis, IN 46256
855-527-2246
https://sequencing.roche.com/en-us.html

REQUEST INFO: AVENIO ctDNA Surveillance Kits (Roche)

Benefits

  • Confidently report all four mutation classes: SNVs, indels, fusions, and CNVs.
  • Delivers exceptional analytical performance supported by integrated digital error suppression (iDES) strategies, combining molecular barcodes with in silico error suppression techniques.
  • Uses an intelligent algorithm that applies population-scale data from multiple cancer databases to design a panel with broad research subject coverage.
  • Enables researchers to detect mutations derived from a variety of solid tumor indications using a single, streamlined workflow.
  • Maximizes the number of mutations detected per tumor while minimizing the panel size, enabling researchers to use the combined power of multiple mutations to increase the detection of ctDNA several fold while minimizing sequencing costs.

Research focus

  • Primary: Lung, Colorectal
  • Secondary: Breast, Gastric, Prostate, Glioma, Melanoma, Ovarian, Thyroid, and Pancreatic

Applications

  • Non-invasive tumor profiling
  • Non-invasive detection of resistance biomarkers
  • Non-invasive serial tumor burden monitoring
  • Non-invasive detection of minimal residual disease
AVENIO ctDNA Surveillance Kits from Roche

AVENIO ctDNA Surveillance Kits (Roche)

Scroll Up

Want to learn more about this product?

Request additional information now.

Download

Download the digital edition of the comprehensive 2020 Insider’s Guide